Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 26, 2023

SELL
$5.9 - $6.95 $4,720 - $5,560
-800 Reduced 4.28%
17,884 $117,000
Q1 2023

May 04, 2023

SELL
$6.18 - $7.99 $309 - $399
-50 Reduced 0.27%
18,684 $126,000
Q4 2022

Jan 26, 2023

BUY
$6.87 - $10.96 $1,401 - $2,235
204 Added 1.1%
18,734 $0
Q2 2022

Jul 25, 2022

SELL
$9.31 - $11.84 $19,923 - $25,337
-2,140 Reduced 10.35%
18,530 $202,000
Q1 2022

Apr 21, 2022

SELL
$10.84 - $16.55 $5,420 - $8,275
-500 Reduced 2.36%
20,670 $234,000
Q4 2021

Feb 01, 2022

SELL
$15.69 - $21.14 $15,690 - $21,140
-1,000 Reduced 4.51%
21,170 $332,000
Q3 2021

Oct 19, 2021

SELL
$15.35 - $21.27 $1,535 - $2,127
-100 Reduced 0.45%
22,170 $380,000
Q1 2021

Apr 20, 2021

BUY
$13.42 - $20.28 $5,368 - $8,112
400 Added 1.83%
22,270 $334,000
Q4 2020

Feb 09, 2021

SELL
$9.77 - $13.81 $3,360 - $4,750
-344 Reduced 1.55%
21,870 $287,000
Q3 2020

Nov 03, 2020

BUY
$9.32 - $12.02 $10,252 - $13,222
1,100 Added 5.21%
22,214 $214,000
Q3 2019

Nov 07, 2019

BUY
$12.27 - $15.79 $4,908 - $6,316
400 Added 1.93%
21,114 $280,000
Q2 2019

Jul 16, 2019

BUY
$13.37 - $18.85 $5,348 - $7,540
400 Added 1.97%
20,714 $292,000
Q1 2019

May 07, 2019

BUY
$17.59 - $31.05 $6,455 - $11,395
367 Added 1.84%
20,314 $374,000
Q4 2018

Feb 07, 2019

SELL
$18.97 - $31.47 $9.51 Million - $15.8 Million
-501,268 Reduced 96.17%
19,947 $521,000
Q4 2018

Feb 05, 2019

BUY
$18.97 - $31.47 $9.89 Million - $16.4 Million
521,215 New
521,215 $20,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $274M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Oregon Public Employees Retirement Fund Portfolio

Follow Oregon Public Employees Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.